The MFDS said it approved lot release of 55,000 doses of Moderna COVID-19 vaccine on the 15th.

The national lot release is a system in which country evaluates the results of the verification test and the review of the manufacturer's data before the vaccine is distributed on the market and checks the quality once more.

The MFDS measured efficacy based on genetic materials and the amount of lipid nanoparticles surrounding them through invitro translation of the first import of Moderna COVID-19 vaccine.

The purity test and endotoxin test confirmed that the vaccine was safe because it was not contaminated. The MFDS explained that quality test data issued by the plant quality as